VRM
MDT icon

Vectors Research Management’s Medtronic MDT Stock Holding History

Vectors Research Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.29M Buy
29,312
+6,021
+26% +$486K 0.6% 53
2026
Q1 		$2.02M Buy
23,291
+119
+0.5% +$11.4K 0.59% 55
2025
Q4 		$2.23M Buy
23,172
+89
+0.4% +$8.64K 0.68% 47
2025
Q3 		$2.2M Buy
23,083
+8,502
+58% +$782K 0.69% 47
2025
Q2 		$1.27M Sell
14,581
-414
-3% -$35.1K 0.44% 61
2025
Q1 		$1.35M Buy
14,995
+364
+2% +$32.6K 0.47% 59
2024
Q4 		$1.17M Sell
14,631
-1,731
-11% -$150K 0.4% 64
2024
Q3 		$1.47M Sell
16,362
-427
-3% -$35.9K 0.45% 63
2024
Q2 		$1.32M Sell
16,789
-499
-3% -$40.9K 0.41% 64
2024
Q1 		$1.51M Buy
17,288
+10,887
+170% +$929K 0.43% 62
2023
Q4 		$527K Buy
+6,401
New +$488K 0.15% 102
2023
Q3 		– Sell
-6,471
Closed -$570K – 133
2023
Q2 		$570K Buy
+6,471
New +$557K 0.16% 101
2022
Q3 		– Sell
-203
Closed -$18K – 340
2022
Q2 		$18K Buy
203
+80
+65% +$8.11K ﹤0.01% 296
2022
Q1 		$14K Sell
123
-155
-56% -$16.4K ﹤0.01% 316
2021
Q4 		$29K Buy
278
+40
+17% +$4.63K 0.01% 307
2021
Q3 		$30K Hold
238
– – 0.01% 276
2021
Q2 		$30K Buy
238
+40
+20% +$5.02K 0.01% 278
2021
Q1 		$23K Sell
198
-983
-83% -$115K 0.01% 273
2020
Q4 		$138K Buy
1,181
+883
+296% +$97.2K 0.04% 149
2020
Q3 		$18K Buy
298
+123
+70% +$12.4K 0.01% 254
2020
Q2 		$16K Sell
175
-24
-12% -$2.3K 0.01% 251
2020
Q1 		$18K Sell
199
-123
-38% -$13.1K 0.01% 239
2019
Q4 		$37K Buy
322
+108
+50% +$11.9K 0.01% 207
2019
Q3 		$23K Buy
214
+1
+0.5% +$104 0.01% 219
2019
Q2 		$21K Hold
213
– – 0.01% 217
2019
Q1 		$19K Buy
213
+1
+0.5% +$90 0.01% 226
2018
Q4 		$19K Buy
212
+1
+0.5% +$93 0.01% 333
2018
Q3 		$19K Buy
+211
New +$19.5K 0.01% 256

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Vectors Research Management's MDT Position: Q2 2026 in Review

Vectors Research Management increased its Medtronic (MDT) stake by 26% in Q2 2026, buying an estimated $486K and bringing the position to 29,312 shares worth $2.29M. The position accounts for 0.6% of the portfolio, ranked #53.

Vectors Research Management first reported a position in MDT in Q3 2018 and has held it in 28 quarters since. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Vectors Research Management held 29,312 shares of Medtronic worth $2.29M as of Q2 2026.
  • Vectors Research Management bought 6,021 Medtronic shares in Q2 2026, an estimated $486K.
  • Medtronic made up 0.6% of Vectors Research Management's portfolio in Q2 2026, its #53 holding.
  • Vectors Research Management first reported a position in Medtronic in Q3 2018 and has held it in 28 quarters since.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Vectors Research Management's 13F filing for Q2 2026, filed 29 Jul 2026.